The effects of a cyclooxygenase-2 (COX-2) expression and inhibition on human uveal melanoma cell proliferation and macrophage nitric oxide production
2007

Effects of COX-2 Inhibition on Uveal Melanoma Cells

Sample size: 5 publication Evidence: moderate

Author Information

Author(s): Marshall Jean-Claude, Caissie Amanda L, Cruess Stephanie R, Cools-Lartigue Jonathan, Burnier Miguel N Jr

Primary Institution: The Henry C. Witelson Ocular Pathology Laboratory and Registry, McGill University

Hypothesis

This study aimed to investigate the effect of a COX-2 inhibitor on the proliferation rate of human uveal melanoma cells and its effect on macrophage nitric oxide production.

Conclusion

Amfenac affected both COX-2 transfected and non-transfected uveal melanoma cells in terms of their proliferation rates and their suppressive effects on macrophage cytotoxic activity.

Supporting Evidence

  • Cells transfected to express COX-2 had a higher proliferation rate than those that did not.
  • The addition of Amfenac significantly decreased the proliferation rate of all cell lines.
  • Nitric oxide production by macrophages was inhibited by the addition of melanoma conditioned medium.

Takeaway

The study found that a drug called amfenac can slow down the growth of certain eye cancer cells and help immune cells work better.

Methodology

Human uveal melanoma cell lines were transfected to express COX-2, and their proliferation rates were measured with and without the addition of amfenac. Nitric oxide production by macrophages was also measured after exposure to melanoma-conditioned medium.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1477-3163-6-17

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication